Article
MAPK-pathway activity, Lrrk2 G2019S, and Parkinson's disease.
Journal of neuroscience research - 1 May 2007
White Linda R, Toft Mathias, Kvam Sylvia N, Farrer Matthew J, Aasly Jan O
Abstract excerpt
The 6055G>A mutation in the leucine-rich repeat kinase 2 (LRRK2) gene results in a G2019S substitution in the mixed-lineage kinase domain of Lrrk2, causing autosomal dominant Parkinson's disease (PD). We hypothesized the mutation alters cellular mitogen-activated protein kinase (MAPK) signalling cascades, and might be detectable in tissues other than in the brain. We therefore compared total levels and activation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
